LONDON, Dec 9 (Reuters) - Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo Nordisk to manage the hormonal disorder's symptoms, ...

For many women in menopause, weight gain becomes more stubborn as hormonal shifts slow metabolism and redistribute fat. Yet new research suggests that one therapeutic approach—combining tirzepatide, ...

Nadia from Trimline Weight Loss & Wellness was back with us this morning along with Paige Rhodes with Your Best Life MD to discuss hormone therapy, and how it can help you in your weight loss journey!

The GLP-1/GIP dual-receptor agonist tirzepatide led to at least 15% loss of total body fat in premenopausal, perimenopausal, and postmenopausal women, but postmenopausal women taking menopausal ...

Once a person reaches menopause, they can often experience a wide array of life-disrupting symptoms, such as hot flashes, disrupted sleep, vaginal dryness, or mood swings. These are due to fluctuating ...

A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a Food and Drug Administration-approved drug for the ...

A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a Food and Drug Administration-approved drug for the ...

L. MACUNGIE TWP., Pa. — Women in the Lehigh Valley have a new resource for addressing stubborn weight gain and hormone-related health challenges. A new location of BeBalanced Natural Hormone Weight ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by ...

Share on Pinterest A combination of hormone therapy and the GLP-1 drug tirzepatide may promote weight loss in postmenopausal females. Image Credit: Mauro Grigollo/Stocksy A new study found that ...